| Product Code: ETC13150720 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Glucose 6 Phosphate Dehydrogenase Deficiency Market was valued at USD 0.4 Billion in 2024 and is expected to reach USD 0.6 Billion by 2031, growing at a compound annual growth rate of 4.70% during the forecast period (2025-2031).
The Global Glucose 6 Phosphate Dehydrogenase Deficiency Market is experiencing steady growth driven by increased awareness, improved diagnostic techniques, and rising prevalence of the condition worldwide. This genetic disorder affects red blood cells, leading to hemolytic anemia and other health complications. The market is characterized by a range of diagnostic tests, treatment options, and research efforts focusing on developing new therapies. Key players in the market include diagnostic companies, pharmaceutical manufacturers, and research institutions collaborating to enhance disease management and patient outcomes. Asia-Pacific region is anticipated to witness significant growth due to a high burden of G6PD deficiency in countries like China and India. Overall, the market is poised for continued expansion as healthcare systems strive to address the unmet needs of individuals affected by this inherited disorder.
The global Glucose 6 Phosphate Dehydrogenase (G6PD) Deficiency market is witnessing a rise in awareness and diagnosis of the condition, driving market growth. Increasing research and development activities aimed at developing effective treatments and therapies for G6PD deficiency are creating opportunities for pharmaceutical companies. The market is also benefiting from advancements in genetic testing technologies, enabling early detection and personalized treatment plans for individuals with the deficiency. Additionally, collaborations between healthcare organizations and research institutions are contributing to the expansion of treatment options and improving patient outcomes. With a growing emphasis on precision medicine and personalized healthcare, the G6PD deficiency market is poised for further growth and innovation in the coming years.
In the Global Glucose 6 Phosphate Dehydrogenase Deficiency market, several challenges are faced, including limited awareness among healthcare professionals and the general population about the condition, leading to underdiagnosis and inadequate management. Additionally, the lack of standardized diagnostic tests and treatment protocols poses a challenge in effectively addressing the disease. Access to appropriate healthcare services and medications can also be limited in certain regions, impacting patient care and outcomes. Furthermore, the complexity of the genetic factors involved in G6PD deficiency adds another layer of challenge in developing targeted therapies. Overall, overcoming these challenges requires collaborative efforts from healthcare providers, researchers, policymakers, and pharmaceutical companies to improve diagnosis, treatment, and overall management of G6PD deficiency on a global scale.
The global Glucose 6 Phosphate Dehydrogenase Deficiency market is primarily driven by factors such as increasing awareness about the condition, rising prevalence of infectious diseases like malaria which often coexist with G6PD deficiency, advancements in diagnostic technologies for early detection, and growing research and development activities focused on finding effective treatments. Additionally, the expanding healthcare infrastructure in developing countries, government initiatives to improve healthcare accessibility, and the rising demand for personalized medicine are also contributing to the market growth. Furthermore, collaborations between pharmaceutical companies and research organizations to develop innovative therapies and genetic testing services are expected to fuel the market expansion in the coming years.
Government policies related to the Global Glucose 6 Phosphate Dehydrogenase (G6PD) Deficiency Market primarily focus on promoting awareness, diagnosis, and treatment of this genetic disorder. Many countries have implemented newborn screening programs to detect G6PD deficiency early on, enabling timely intervention and management. Additionally, governments support research initiatives to develop effective therapies and guidelines for managing the condition. Some regions provide subsidies or financial assistance for G6PD testing and treatment to ensure affordability and accessibility for patients. Overall, government policies aim to improve the quality of care for individuals with G6PD deficiency, reduce the burden of the disease on healthcare systems, and enhance public health outcomes.
The Global Glucose 6 Phosphate Dehydrogenase Deficiency Market is expected to witness steady growth in the coming years, driven by increasing awareness about the condition, advancements in diagnostic technologies, and rising prevalence of the deficiency in certain regions. The market is likely to benefit from ongoing research and development efforts aimed at developing novel treatments and therapies for managing the symptoms associated with G6PD deficiency. Additionally, the growing adoption of personalized medicine approaches and genetic testing services is anticipated to further propel market growth. However, challenges such as limited access to healthcare in developing countries and lack of standard treatment guidelines may hinder market expansion to some extent. Overall, the Global G6PD Deficiency Market is poised for incremental growth opportunities in the foreseeable future.
In the global Glucose 6 Phosphate Dehydrogenase (G6PD) deficiency market, different regions exhibit varying trends. Asia Pacific has a high prevalence of G6PD deficiency due to genetic factors, with countries like China, India, and Southeast Asian nations contributing significantly to the market growth. North America and Europe also have a notable number of cases, but awareness and diagnostic rates are higher, leading to better management and treatment options. In the Middle East and Africa, G6PD deficiency is prevalent in certain populations, often due to the increased incidence of malaria. In Latin America, the market is driven by improving healthcare infrastructure and rising awareness about the condition. Overall, the market dynamics in each region are influenced by factors such as population demographics, healthcare access, and genetic predispositions.
Global Glucose 6 Phosphate Dehydrogenase Deficiency Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Revenues & Volume, 2021 & 2031F |
3.3 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market - Industry Life Cycle |
3.4 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market - Porter's Five Forces |
3.5 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.8 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Trends |
6 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, 2021 - 2031 |
6.1 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Oxygen Therapy, 2021 - 2031 |
6.1.3 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Blood Transfusion, 2021 - 2031 |
6.1.4 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Genetic Counseling, 2021 - 2031 |
6.1.5 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Others, 2021 - 2031 |
6.1.6 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
6.1.7 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Complete Blood Count, 2021 - 2031 |
6.2 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Rapid Heart Rate, 2021 - 2031 |
6.2.3 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Shortness of Breath, 2021 - 2031 |
6.2.4 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Dark Urine, 2021 - 2031 |
6.2.5 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Fever, 2021 - 2031 |
6.2.6 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Fatigue, 2021 - 2031 |
6.2.7 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Dizziness, 2021 - 2031 |
6.2.8 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Jaundice,, 2021 - 2031 |
6.2.9 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Clinic, 2021 - 2031 |
6.3.3 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Hospital, 2021 - 2031 |
6.3.4 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.4.3 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.4.4 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
7 North America Glucose 6 Phosphate Dehydrogenase Deficiency Market, Overview & Analysis |
7.1 North America Glucose 6 Phosphate Dehydrogenase Deficiency Market Revenues & Volume, 2021 - 2031 |
7.2 North America Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.4 North America Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
7.5 North America Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6 North America Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Glucose 6 Phosphate Dehydrogenase Deficiency Market, Overview & Analysis |
8.1 Latin America (LATAM) Glucose 6 Phosphate Dehydrogenase Deficiency Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.4 Latin America (LATAM) Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
8.5 Latin America (LATAM) Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8.6 Latin America (LATAM) Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Glucose 6 Phosphate Dehydrogenase Deficiency Market, Overview & Analysis |
9.1 Asia Glucose 6 Phosphate Dehydrogenase Deficiency Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.4 Asia Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
9.5 Asia Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9.6 Asia Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Glucose 6 Phosphate Dehydrogenase Deficiency Market, Overview & Analysis |
10.1 Africa Glucose 6 Phosphate Dehydrogenase Deficiency Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.4 Africa Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
10.5 Africa Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10.6 Africa Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Glucose 6 Phosphate Dehydrogenase Deficiency Market, Overview & Analysis |
11.1 Europe Glucose 6 Phosphate Dehydrogenase Deficiency Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.4 Europe Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
11.5 Europe Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11.6 Europe Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Glucose 6 Phosphate Dehydrogenase Deficiency Market, Overview & Analysis |
12.1 Middle East Glucose 6 Phosphate Dehydrogenase Deficiency Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.4 Middle East Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Symptoms, 2021 - 2031 |
12.5 Middle East Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12.6 Middle East Glucose 6 Phosphate Dehydrogenase Deficiency Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Key Performance Indicators |
14 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market - Export/Import By Countries Assessment |
15 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market - Opportunity Assessment |
15.1 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.3 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
15.4 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Opportunity Assessment, By End-Users, 2021 & 2031F |
15.5 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market - Competitive Landscape |
16.1 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Revenue Share, By Companies, 2024 |
16.2 Global Glucose 6 Phosphate Dehydrogenase Deficiency Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here